Tirzepatide Shows Promise in CKD and Type 2 Diabetes with Obesity | Retatrutide News

A study evaluated tirzepatide's effects on metabolic and kidney outcomes in CKD and T2DM patients with obesity. This research highlights the potential o...
Clinical Trials · October 20, 2026